Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Building A Foundation: Express Scripts’ Miller On Recent Outcomes-Based Contracts

Executive Summary

In an interview, the PBM's chief medical officer discusses outcomes-based contracts, comments on whether the drug pricing debate will be impacted by slowing growth in drug spending, and notes an upcoming focus at the PBM on controlling diabetes drug costs

Advertisement

Related Content

US Outcomes-Based Contracts: Big Uptick In Interest, But Not Execution
Lilly, Anthem Singing Same Tune On Value-Based Pricing, Communication Policy
Express Scripts Turns To Compounding To Fight High-Priced Off-Patent Drugs

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS057478

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel